Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances: 2013-2024

Historic Long-Term Debt Issuances for Fortress Biotech (FBIO) over the last 4 years, with Dec 2024 value amounting to -$33.7 million.

  • Fortress Biotech's Long-Term Debt Issuances fell 220.42% to -$33.7 million in Q4 2024 from the same period last year, while for Sep 2024 it was $61.7 million, marking a year-over-year increase of 266.23%. This contributed to the annual value of $28.0 million for FY2023, which is 460.00% up from last year.
  • Latest data reveals that Fortress Biotech reported Long-Term Debt Issuances of -$33.7 million as of Q4 2024, which was down 200.00% from $33.7 million recorded in Q3 2024.
  • In the past 5 years, Fortress Biotech's Long-Term Debt Issuances registered a high of $42.1 million during Q1 2022, and its lowest value of -$42.1 million during Q2 2022.
  • For the 3-year period, Fortress Biotech's Long-Term Debt Issuances averaged around $4.1 million, with its median value being $16.5 million (2022).
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first spiked by 460.00% in 2023, then slumped by 220.42% in 2024.
  • Quarterly analysis of 4 years shows Fortress Biotech's Long-Term Debt Issuances stood at $7.0 million in 2021, then decreased by 28.57% to $5.0 million in 2022, then surged by 460.00% to $28.0 million in 2023, then crashed by 220.42% to -$33.7 million in 2024.
  • Its Long-Term Debt Issuances was -$33.7 million in Q4 2024, compared to $33.7 million in Q3 2024 and $28.0 million in Q4 2023.